Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Evaluation of a Novel Trifocal IOL

NCT: NCT07587138 · NOT_YET_RECRUITING

NCT IDNCT07587138
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2027-07

Brief Summary

The purpose of this study is to understand the visual outcomes of the investigational intraocular lens (IOL) Model LPYWT0 when compared to the commercially marketed Clareon PanOptix Pro IOL Model PXYWT0.

Frequently Asked Questions

What is Clinical Evaluation of a Novel Trifocal IOL?

Clinical Evaluation of a Novel Trifocal IOL is a clinical trial registered under NCT07587138. Current status: NOT_YET_RECRUITING.

What is the status of NCT07587138?

The current status of NCT07587138 (Clinical Evaluation of a Novel Trifocal IOL) is: NOT_YET_RECRUITING.

When did Clinical Evaluation of a Novel Trifocal IOL start?

Clinical Evaluation of a Novel Trifocal IOL started on 2026-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.